LSTA

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended March 31, 1998, for Corniche Group Incorporated (also referenced as Lisata Therapeutics, Inc. in metadata, though the filing identifies Corniche Group). The company underwent a significant change in control and business strategy during the period. Following the receivership of its UK stationery subsidiaries in 1996, the company had no operating revenues. In May 1998, stockholders approved a transaction issuing Series B Convertible Redeemable Preferred Stock to Joel San Antonio and others, granting them control. The company's new strategic focus is entering the property and casualty insurance market, specifically targeting "short tail" casualty business and niche opportunities.

Key Financial Metrics

Liquidity and Debt: The company improved its liquidity significantly through private placements of common stock, raising approximately $1.79 million in net proceeds during the fiscal year. Notes payable of $400,000 outstanding in 1997 were paid in full in 1998. As of March 31, 1998, the company held no long-term debt but had accrued preferred stock dividends of $208,464.

Material Changes vs. Prior Period

• Turnaround in Liquidity: The company moved from a working capital deficiency of $(652,456) in 1997 to a surplus of $869,567 in 1998, driven by equity financing rather than operations.
• Reduction in Losses: Operating losses decreased by approximately $30,000 year-over-year, primarily due to reduced general and administrative expenses.
• Change in Control: A transaction consummated in May 1998 resulted in Joel San Antonio obtaining control via Series B Preferred Stock, shifting the company's direction from a shell entity to an insurance-focused startup.
• Asset Composition: Total assets increased from $14,914 to over $1.1 million, almost entirely consisting of cash raised from securities offerings.

Outlook, Risks, and Management Commentary

Guidance and Strategy: Management anticipates no operating revenues until the company secures insurance licenses or consummates an acquisition. The company has entered a non-binding letter of intent to acquire an existing insurance company with limited operations. Success depends on obtaining regulatory licenses and raising additional capital to meet regulatory requirements.

Risks and Contingencies:

• Going Concern: While auditors issued an unqualified opinion for 1998, previous reports (1996, 1997) noted substantial doubt about the company's ability to continue as a going concern. The company remains dependent on future financing.
• Regulatory Hurdles: Entry into the insurance market requires satisfying state regulatory capital requirements, which the company has not yet secured.
• Acquisition Uncertainty: The proposed acquisition of an insurance company is subject to due diligence and material conditions; consummation is not assured.
• Unpaid Receivables: The company does not anticipate further cash recovery on a $75,000 note receivable from a former subsidiary sale, though it retains an option to purchase shares in the parent company.

Investor Verification Checklist

• Capital Sufficiency: Verify if the company has raised the additional equity capital required to meet insurance regulatory capital standards.
• Acquisition Status: Confirm whether the non-binding letter of intent to acquire an insurance company has been finalized or abandoned.
• Licensing Progress: Check for updates on obtaining necessary state insurance licenses to conduct operations.
• Preferred Stock Terms: Review the redemption terms of the Series B Preferred Stock, which may be redeemed for $0.10 per share unless specific stock price or revenue triggers are met by March 31, 2000.
• Management Continuity: Monitor the implementation of the new business plan by the newly elected management team (San Antonio, Hutchins, Glime, Aber).